CD163 and systemic sclerosis: Concerning the M2 phenotype markers, a relevant presence of CD204+cells, CD206+cells and CD163+cells was observed in the stroma and primarily in the alveoli of SSc-ILD patients: their percentages were significantly higher than those observed in controls (p<0.0001) (Figures 3–5).